Literature DB >> 19293327

Wfs1 gene deletion causes growth retardation in mice and interferes with the growth hormone pathway.

S Kõks1, U Soomets, J L Paya-Cano, C Fernandes, H Luuk, M Plaas, A Terasmaa, V Tillmann, K Noormets, E Vasar, L C Schalkwyk.   

Abstract

The aim of present study was to describe changes in gene expression in the temporal lobe of mice induced by deletion of the Wfs1 gene. Temporal lobes samples were analyzed using Affymetrix Mouse Genome 420 2 GeneChips and expression profiles were functionally annotated with GSEA and Ingenuity Pathway Analysis. We found that Wfs1 mutant mice are significantly smaller (20.9 +/- 1.6 g) than their wild-type counterparts (31.0 +/- 0.6 g, P < 0.0001). This difference existed in 129S6 and C57B6 backgrounds. Interestingly, microarray analysis identified upregulation of growth hormone (GH) transcripts and functional analysis revealed activation of GH pathways. In line with microarray data, the level of IGF-1 in the plasma of Wfs1 mutant mice was significantly increased (P < 0.05). Thus, Wfs1 deletion induces growth retardation, whereas the GH pathway is activated. To test the interaction between the Wfs1 deletion and genomic background, mutant mice were backcrossed to two different genetic backgrounds. In line with previous studies, an interaction between a gene knockout and genetic background was found in gene expression profiles in the congenic region. However, genetic background did not alter the effect of the Wfs1 mutation on either body weight or GH pathway activation. Further studies are needed to describe biochemical and molecular changes of the growth hormone axis as well as in other hormones to clarify their role in growth retardation in the Wfs1 mutant mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19293327     DOI: 10.1152/physiolgenomics.90407.2008

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  17 in total

1.  Impaired striatal dopamine output of homozygous Wfs1 mutant mice in response to [K+] challenge.

Authors:  Vallo Matto; Anton Terasmaa; Eero Vasar; Sulev Kõks
Journal:  J Physiol Biochem       Date:  2010-10-23       Impact factor: 4.158

2.  Wfs1 mutation makes mice sensitive to insulin-like effect of acute valproic acid and resistant to streptozocin.

Authors:  Anton Terasmaa; Ursel Soomets; Julia Oflijan; Marite Punapart; Mats Hansen; Vallo Matto; Kersti Ehrlich; Anne Must; Sulev Kõks; Eero Vasar
Journal:  J Physiol Biochem       Date:  2011-04-02       Impact factor: 4.158

3.  Wolframin is a novel regulator of tau pathology and neurodegeneration.

Authors:  Diana Acosta; Liangping Li; Shuo Chen; Jiawen Liang; Yuzhou Chang; Cankun Wang; Julie Fitzgerald; Cody Morrison; Chris N Goulbourne; Yoshi Nakano; Nancy C Hernandez Villegas; Lalitha Venkataraman; Cris Brown; Geidy E Serrano; Erica Bell; Trina Wemlinger; Min Wu; Olga N Kokiko-Cochran; Phillip Popovich; Xena E Flowers; Lawrence S Honig; Jean Paul Vonsattel; Douglas W Scharre; Thomas G Beach; Qin Ma; Jeff Kuret; Sulev Kõks; Fumihiko Urano; Karen E Duff; Hongjun Fu
Journal:  Acta Neuropathol       Date:  2022-04-07       Impact factor: 15.887

4.  Activation of the sigma-1 receptor chaperone alleviates symptoms of Wolfram syndrome in preclinical models.

Authors:  Lucie Crouzier; Alberto Danese; Yuko Yasui; Elodie M Richard; Jean-Charles Liévens; Simone Patergnani; Simon Couly; Camille Diez; Morgane Denus; Nicolas Cubedo; Mireille Rossel; Marc Thiry; Tsung-Ping Su; Paolo Pinton; Tangui Maurice; Benjamin Delprat
Journal:  Sci Transl Med       Date:  2022-02-09       Impact factor: 19.319

5.  Male mice with deleted Wolframin (Wfs1) gene have reduced fertility.

Authors:  Klari Noormets; Sulev Kõks; Ants Kavak; Andres Arend; Marina Aunapuu; Aivi Keldrimaa; Eero Vasar; Vallo Tillmann
Journal:  Reprod Biol Endocrinol       Date:  2009-08-10       Impact factor: 5.211

6.  SYSGENET: a meeting report from a new European network for systems genetics.

Authors:  Klaus Schughart
Journal:  Mamm Genome       Date:  2010-07-11       Impact factor: 2.957

Review 7.  At the dawn of the transcriptomic medicine.

Authors:  Gea Koks; Abigail L Pfaff; Vivien J Bubb; John P Quinn; Sulev Koks
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-11

8.  Effect of chronic valproic Acid treatment on hepatic gene expression profile in wfs1 knockout mouse.

Authors:  Marite Punapart; Mall Eltermaa; Julia Oflijan; Silva Sütt; Anne Must; Sulev Kõks; Leonard C Schalkwyk; Catherine Fernandes; Eero Vasar; Ursel Soomets; Anton Terasmaa
Journal:  PPAR Res       Date:  2014-04-01       Impact factor: 4.964

9.  Behavioral characterization of a novel Cisd2 mutant mouse.

Authors:  Christiann H Gaines; Angela E Snyder; Robin B Ervin; Joseph Farrington; Kenneth Walsh; Sarah A Schoenrock; Lisa M Tarantino
Journal:  Behav Brain Res       Date:  2021-02-18       Impact factor: 3.332

10.  Expression Quantitative Trait Loci (eQTLs) Associated with Retrotransposons Demonstrate their Modulatory Effect on the Transcriptome.

Authors:  Sulev Koks; Abigail L Pfaff; Vivien J Bubb; John P Quinn
Journal:  Int J Mol Sci       Date:  2021-06-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.